Publications by authors named "Angela Cramer"

Claim this Profile
C
Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results.
Nigel Bundred, Nuria Porta, Adrian Murray Brunt, Angela Cramer, Andrew Hanby

Clin Cancer Res· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FAK inhibition alone or in combination with adjuvant therapies reduces cancer stem cell activity.
Simon Timbrell, Hosam Aglan, Angela Cramer, Phil Foden, David Weaver

NPJ Breast Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The HER3 pathway as a potential target for inhibition in patients with biliary tract cancers.
Angela Lamarca, Salvatore Galdy, Jorge Barriuso, Sharzad Moghadam, Elizabeth Beckett, Angela Cramer

PLoS One· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient- and Provider-Centered Design of an Outpatient Diabetes Technology Clinic.
Angela M Cramer, Patricia Scalzo, Sarah M Bach, Yogish C Kudva

J Diabetes Sci Technol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of acute and chronic low density lipoprotein exposure on neutrophil function.
Tatsiana Palvinskaya, Maryellen Antkowiak, Elianne Burg, Christopher C Lenox, Niki Ubags, Angela Cramer

Pulm Pharmacol Ther· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nursing workload measurement in ambulatory care.
Katherine L Dickson, Angela M Cramer, Colleen M Peckham

Nurs Econ· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclooxygenase-2 inhibition does not improve the reduction in ductal carcinoma in situ proliferation with aromatase inhibitor therapy: results of the ERISAC randomized placebo-controlled trial.
Nigel J Bundred, Angela Cramer, Julie Morris, Lorna Renshaw, Kwok-Leung Cheung

Clin Cancer Res· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absence of HER4 expression predicts recurrence of ductal carcinoma in situ of the breast.
Nicola L P Barnes, Sahar Khavari, Gary P Boland, Angela Cramer, W Fiona Knox

Clin Cancer Res· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-term biologic response to withdrawal of hormone replacement therapy in patients with invasive breast carcinoma.
Ramachandran Prasad, Gary P Boland, Angela Cramer, Elizabeth Anderson, W Fiona Knox

Cancer· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis